Flora Growth acquired Franchise Global Health in a medical marijuana deal in which FGH is valued at approximately C$40 million (approximately $29.2 million USD).
Flora Growth is an all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands. Flora leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its commercial, house brands and life sciences divisions.
Franchise Global Health Inc., through its subsidiaries, is a multinational operator in the medical cannabis and pharmaceutical industries, with principal operations in Germany and with operations, assets, strategic partnerships and investments internationally.
According to the LevinPro HC database, this is the 81st Pharmaceuticals deal of 2022. This compares with 39 Pharmaceuticals transactions recorded between January 1, 2021, and October 24, 2021.
